glp 1 and gip function Targeting GLP-1, & GCG in Obesity Type 2 Diabetes Research GIP and GLP‐1, the two

Mild side effects such as nausea, vomiting, diarrhea, and constipation were more frequent in the retatrutide group

This protocol simplicity is one reason this escalation produces high adherence rates in clinical trials and why it translates well to research applications

Seek support: Encourage patients to connect with support groups, friends, or family members who can help them stay motivated and accountable

Abstract Weight loss, whether resulting from disease-related conditions or intentional interventions, has been increasingly recognized as a significant risk factor for compromised skeletal integrity

The issue of obesity and insulin resistance prompted the design of a number of studies investigating the effects of antidiabetic drugs in PCOS, as reported in recent and very exhaustive reviews on the available clinical trials on glucagon-like peptide 1 receptor agonists (GLP-1RA) in PCOS [21, 23, 24]